Anaergia, Inc. · TSX:ANRG

Anaergia — Q2 2021 Earnings Presentation

15 slides from Anaergia's earnings presentation, Aug 13, 2021

  1. Slide 1: Anaergia Inc. Q2 2021 Results Investor Conference Call

    Anaergia Inc. Q2 2021 Results Investor Conference Call August 13, 2021 TSX: ANRG Fueling a Sustainable World

  2. Slide 2: Disclaimers

    Disclaimers Forward-Looking Information Certain statements in this presentation and certain oral statements made by senior management during the earnings conference call on August 13, 2021(collectively, this "presentation") are “forward-looking information” within the meaning of applicable Canadian

  3. Slide 3: Participating in Today's Call

    Participating in Today’s Call 3

  4. Slide 4: Key Q2 Highlights

    Key Q2 Highlights QUARTERLY Expanded to $175M $3.2B REVENUE (C$ millions) North-East IPO Revenue Backlog1 Acquired the Rhode Island Completed the initial public offering, Value of Q2 closing Revenue Backlog, Bioenergy Facility, LLC. began trading on the TSX represents a 15% quarterly increase 43.6 %

  5. Slide 5: IPO & Capitalization Summary

    IPO & Capitalization Summary IPO Highlights Brokerage Firms that Launched Research Coverage Began Trading on June 23, 2021. Issue Price (CAD): Analyst TSX: ANRG $14.00 Aaron MacNeil Subordinate Voting Shares Issued: Raised Gross proceeds of: 12 500 000 $175M Moses Sutton Subsequent to Q2 2021, the u

  6. Slide 6: Market, Bookings and Backlog Growth

    Market, Bookings and Backlog Growth Q2 2021 CLOSING REVENUE CONTINUED REVENUE • ~$499 million in new bookings, BACKLOG1 BACKLOG1 GROWTH primarily driven by the Rhode Island BOO project acquisition plus Italian BOO projects, helped increase the Capital Sales closing Revenue Backlog of Q2 2021 Service

  7. Slide 7: Financial Summary

    Financial Summary • Significant Revenue growth in Q2 and first half of 2021 Q2 Q2 YTD YTD (Millions CAD) Change Change • Profitability up in Q2 and first half of 2021 2021 2020 2021 2020 • In California, the COVID-19 pandemic is causing a Revenues 32.1 22.4 44% 69.6 45.6 52% sluggish recovery in the

  8. Slide 8: Business Development – Our Segments

    Business Development – Our Segments CAPITAL SALES SERVICES BUILD-OWN-OPERATE Business Segment • Sales of proprietary technology solutions, • Third-party O&M and service contracts • Build, Own, and Operate greenfield or equipment, and services to third parties ~5-10 years in length brownfield facilit

  9. Slide 9: Capital Sales

    Capital Sales CAD Million Q2 2021 Q2 2020 Change Capital Sales Revenues $28.5 $19.2 49% Increasing Demand for Proprietary Anaergia Technology • Capital sales continue to provide a steady and growing stream of cash-positive revenue and entrance into new markets Rapid Capital Sales Growth in EMEA In N

  10. Slide 10: Services and BOO

    Services and BOO CAD Million Q2 2021 Q2 2020 Change Services $3.0 $2.6 16% BOO $0.6 $0.6 - Capital Sales Growth Provides for Increase of Opportunities in the Services Segment • Growing Capital Sales to third parties increasing service and O&M agreements with customers including municipalities and pr

  11. Slide 11: BOO Updates

    BOO Updates Annual RNG Output Consolidated CAPEX1 Run-Rate Status No. of Projects (MMBTU) (C$ in millions) EBITDA2 $73M ANAERGIA’S Operating 3 985,000 ~$234 ~$62 M PROPORTIONATE INTEREST OF 7 1,251,000 ~$248 ~$48 M RUN-RATE In Construction or starting execution EBITDA4 Contracted in 2021 1 114,000 ~

  12. Slide 12: Rhode Island Bioenergy Facility

    Rhode Island Bioenergy Facility “This plant helps provide security to the future growth and success of this important industry.” - Jesse Saglio, Rhode Island President of Commerce 320,000 MMBTU/YR of RNG 100,000 Tonnes/YR of Waste Diverted 5x EBITDA Build Cost Multiple1 21% Unlevered IRR (1) Please

  13. Slide 13: Q&A

    Q&A 13

  14. Slide 14: Thank you for attending

    Thank you for attending 14

  15. Slide 15: Appendix

    Appendix Adjusted EBITDA: Is calculated by adding and deducting, as applicable, certain expenses, costs, charges or benefits incurred in such period which in management’s view are either not indicative of underlying business performance or impact the ability to assess the operating performance of ou

Anaergia — Q2 2021 Earnings Presentation on 6ix